Počet záznamov: 1  

A Kir6.2 mutation causing severe functional effects in vitro produces neonatal diabetes without the expected neurological complications

  1. NázovA Kir6.2 mutation causing severe functional effects in vitro produces neonatal diabetes without the expected neurological complications
    Autor Tammaro P.
    Spoluautori Flanagan S.E.

    Zadek B.

    Sriram Srinivasan

    Woodhead H.

    Hameed S.

    Klimeš Iwar SAVEXEND - Ústav experimentálnej endokrinológie SAV

    Hattersley A. T.

    Ellard S.

    Ashcroft F. M.

    Zdroj.dok. Diabetologia. Vol. 51, no. 5 (2008), p. 802-810
    Jazyk dok.eng - angličtina
    Druh dok.rozpis článkov z periodík (rbx)
    OhlasyWaterfield T, Gloyn AL: Monogenic ß-cell dysfunction in children: Clinical phenotypes, genetic etiology and mutational pathways. PEDIATRIC HEALTH 2(4): 517-532, 2008.
    Chen, F., Zheng, D., Xu, Y., Luo, Y., Li, H., Yu, K., Song, Y., Zhong, W., Ji, Y. Down-regulation of Kir6.2 affects calcium influx and insulin secretion in HIT-T15 cells. Journal of Pediatric Endocrinology and Metabolism Volume 23, Issue 7, 2010, Pages 709-717.
    Remedi, M.S., Koster, J.C. KATP channelopathies in the pancreas. Pflugers Archiv European Journal of Physiology, Volume 460, Issue 2, July 2010, Pages 307-320.
    Noczyńska, A. , Zubkiewicz-Kucharska, A. , Salmonowicz, B. , Małecki, M. , Młynarski, W. Three-year observation of permanent neonatal diabetes. Endokrynologia, Diabetologia i Choroby Przemiany Materii Wieku Rozwojowego Volume 16, Issue 1, 2010, Pages 50-54.
    Greeley, S.A.W., Tucker, S.E., Worrell, H.I., Skowron, K.B., Bell, G.I., Philipson, L.H. Update in neonatal diabetes. Current Opinion in Endocrinology, Diabetes and Obesity, Volume 17, Issue 1, February 2010, Pages 13-19.
    Avery, P., Mousa, S.S., Mousa, S.A. Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine, Cited by since 1996.
    Lang, V., Youssef, N., Light, P.E. The Molecular Genetics Of Sulfonylurea Receptors In The Pathogenesis And Treatment Of Insulin Secretory Disorders And Type 2 Diabetes current Diabetes Reports 11 (6) pp. 543-551 2011
    Wang, H.-R., Wu, M., Yu, H., Long, S., Stevens, A., Engers, D.W., Sackin, H., Li M, Mcmanus, O.B. Result2 Selective Inhibition Of The K Ir2 Family Of Inward Rectifier Potassium Channels By A Small Molecule Probe: The Discovery, Sar, And Pharmacological Characterization Of Ml133 ACS CHEMICAL BIOLOGY 6 (8) , PP. 845-856 2011
    MYSLIWIEC, M.: Modulators of K+ channels in diabetology. POTASSIUM CHANNELS AS A TARGET FOR CLINICAL THERAPEUTICS pp. 43-60
    STOCKAND, James D. Renal Ion Channels, Electrophysiology of Transport, and Channelopathies. In Seldin and Geibisch's The Kidney, 2013, vol. 1, pp. 217-262.
    HASHIMOTO, Yukiko - DATEKI, Sumito - HIROSE, Masakazu - SATOMURA, Kenichi - SAWADA, Hirotake - MIZUNO, Haruo - SUGIHARA, Shigetaka - MARUYAMA, Koichi - URAKAMI, Tatsuhiko - SUGAWARA, Hidenori - SHIRAI, Kenji - YORIFUJI, Tohru. Molecular and clinical features of K-ATP-channel neonatal diabetes mellitus in Japan. In PEDIATRIC DIABETES. ISSN 1399-543X, 2017, vol. 18, no. 7, pp. 532-539.
    KategóriaADCA - Vedecké práce v zahraničných karentovaných časopisoch impaktovaných
    Kategória (od 2022)V3 - Vedecký výstup publikačnej činnosti z časopisu
    Typ výstupučlánok
    Rok vykazovania2008
    Registrované vWOS
    Registrované vSCOPUS
    DOI 10.1007/s00125-008-0923-1
    článok

    článok

    rokCCIFIF Q (best)JCR Av Jour IF PercSJRSJR Q (best)CiteScore
    A
    rok vydaniarok metrikyIFIF Q (best)SJRSJR Q (best)
    200820075.822Q12.800Q1
Počet záznamov: 1  

  Tieto stránky využívajú súbory cookies, ktoré uľahčujú ich prezeranie. Ďalšie informácie o tom ako používame cookies.